Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Inflation rises again ahead of rates call

Inflation has risen to 4.3 per cent, just days before the Reserve Bank's next interest rates meeting.

Inflation rises again ahead of rates call

Australia's inflation rate unexpectedly accelerated in September, signaling a potential interest rate increase next week, according to the Australian Bureau of Statistics (ABS). The consumer price index jumped to 0.8 percent, up from 0.4 percent in August, pushing annual inflation to 4.3 percent from 4 percent the previous month.

Housing prices were the main driver, surging by 5.2 percent, while transport costs, mainly due to rising fuel prices, added another 9.4 percent. The annual trimmed mean, which gauges underlying inflation, also climbed to 3.6 percent in September, a revision from 3.5 percent in August. Despite the fuel price volatility, inflation worries are mounting, with market forecasts for a November rate hike at around 85 percent, as per Bloomberg data.

KPMG Australia's chief economist, Brendan Rynne, termed the inflation figures as the final piece the Reserve Bank of Australia (RBA) needs to hike the cash rate for the fifth time in 2024. The RBA's inflation target sits between 2-3 percent, and recent data suggests inflation pressures are intensifying, surpassing market expectations.

The RBA's interest rate-setting board is set to convene on Monday, with a decision expected on Tuesday afternoon, along with an update to its economic forecasts, including inflation predictions.

Written by urgent.news from ABC News AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at smh.com.au →

More in Finance & Markets

Brazil Drugmaker Profit Up 16% as Diet Pen Debuts

Hypera, a São Paulo drugmaker, posted third-quarter profit up 16.1% to US$98 million as its Semavy weight-loss pen sold 93,000 units in September.

  • Hypera's profit increased 16.1% to R$527 million in Q3 2023
  • New weight-loss drug Semavy debuted, accounting for 11% of market
  • Net debt decreased to R$5.6 billion during the quarter

More from Wednesday 28 October →